Stockreport

Therapix expects to have results of Tourette's drug trial by end of first quarter [Reuters (UK)]

THERAPIX BIOSCIENCES LTD AMERICAN DEPOSITARY SHARE  (TRPX) 
US:NASDAQ Investor Relations: nasdaq.com/symbol/trpx
PDF Therapix expects to have results of Tourette's drug trial by end of first quarter | Reuters 3 Min Read TEL AVIV (Reuters) - Israel’s Therapix Biosciences said on Monday [Read more]